Dataset Information


Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer.

ABSTRACT: Cobicistat (3, GS-9350) is a newly discovered, potent, and selective inhibitor of human cytochrome P450 3A (CYP3A) enzymes. In contrast to ritonavir, 3 is devoid of anti-HIV activity and is thus more suitable for use in boosting anti-HIV drugs without risking selection of potential drug-resistant HIV variants. Compound 3 shows reduced liability for drug interactions and may have potential improvements in tolerability over ritonavir. In addition, 3 has high aqueous solubility and can be readily coformulated with other agents.

PROVIDER: S-EPMC4007915 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4694690 | BioStudies
| S-EPMC4108106 | BioStudies
| S-EPMC4413526 | BioStudies
| S-EPMC5655101 | BioStudies
| S-EPMC4575373 | BioStudies
| S-EPMC4752462 | BioStudies
| S-EPMC3583342 | BioStudies
| S-EPMC5172523 | BioStudies
| S-EPMC6496093 | BioStudies
| S-EPMC5942200 | BioStudies